Please wait while we open this resource.
RISK FOR BLEEDING-RELATED HOSPITALIZATIONS DURING USE OF AMIODARONE WITH APIXABAN OR RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION — OslerMarket